Lipid Metabolism

A section of Metabolites (ISSN 2218-1989).

Section Information


The “Lipid Metabolism” section accepts manuscripts of original research and high-quality reviews on all aspects of lipid metabolism, including lipoproteins, with a particular focus on biomarkers of risk. This section accepts research papers on the clinical significance of plasma lipid and lipoprotein alterations in acute and chronic diseases, including obesity, diabetes, and cardiovascular disease, with special interest regarding alterations related to cardiometabolic risk. In addition, research papers on the therapeutic modulation of plasma lipids and lipoproteins, including the role of lifestyle, nutraceuticals, and drugs, are also welcome, with novel therapeutic approaches being of particular interest. Finally, this section welcomes the submission of International Consensus Documents.


Topics of interest include, but are not limited to:

  • Identification of novel risk biomarkers
  • The clinical significance of plasma lipid and lipoprotein alterations
  • The evaluation of novel biomarkers in acute and chronic diseases
  • The role of lifestyle and nutraceuticals
  • The role of novel therapeutic approaches in treating metabolic disease

Editorial Board

Papers Published

Back to TopTop